The GO and KEGG pathway enrichment analysis suggests that these significant biomarkers mainly enrich on metabolic process, molecular binding functions and four signalling pathways (Jak-STAT, cell cycle, p53 and pathways in cancer). The gene discussed is TP53; the disease is cancer.